Announcements Trials
Browse Landscape

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 6Observational 4Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 5Classical hematology 4Lymphoid 1

Conditions

Neoplasms 68Venous Thromboembolism 60Anemia 33Leukemia, Myeloid, Acute 28Anemia, Sickle Cell 26Multiple Myeloma 25Hematologic Neoplasms 25Myelodysplastic Syndromes 24Febrile Neutropenia 24Leukemia 22Lymphoma 19Anemia, Aplastic 19Thrombocytopenia 17Myeloproliferative Disorders 16Breast Neoplasms 16Anemia, Refractory, with Excess of Blasts 16Neutropenia 14Venous Thrombosis 13Lymphoma, Non-Hodgkin 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasms, Plasma Cell 12Lung Neoplasms 12Hodgkin Disease 12Fanconi Anemia 12Colorectal Neoplasms 12Ovarian Neoplasms 11Leukemia, Lymphocytic, Chronic, B-Cell 10Thrombosis 9Pulmonary Embolism 9Pancreatic Neoplasms 9

Interventions

fludarabine 2fludarabine phosphate 1Thiotepa 1Melphalan 1Clofarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Hemoglobinopathies × Classical hematology × Clear all
NCT03609840 2023-09-21

Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

NCT01316549 2021-10-04

HCT

University of California, San Francisco

Completed
67 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

NCT03609814 2021-10-04

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)

University of California, San Francisco

Completed
30 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

NCT03609827 2021-10-04

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡